Role of the extracellular matrix in cell–cell communication: a new therapeutic target?

Thorsten Kessler,Hendrik B Sager,Matthias Mann

DOI: https://doi.org/10.1093/eurheartj/ehad061

IF: 39.3

2023-02-19

European Heart Journal

Abstract:Ischaemic heart disease—the major cause of morbidity and death in the European Union and worldwide—is a consequence of coronary artery disease—the manifestation of atherosclerosis at the coronary vasculature—and myocardial infarction. In the past decades, lifestyle interventions, pharmacological treatment, and revascularization procedures markedly improved outcomes. It has been known for decades that atherosclerosis represents an inflammatory disease of the vascular wall. In the past, however, pharmacological treatment strategies mainly focused on platelet inhibition and statin treatment to lower LDL cholesterol and achieve further beneficial effects. Just recently, the CANTOS trial confirmed that anti-inflammatory treatments have beneficial effects in high-risk individuals. 1 All established strategies, however, have in common that they focus on circulating cells which are involved in thrombus formation (i.e. platelets) or recruited to atherosclerotic plaques (i.e. monocytes, neutrophils, and so on.). In constrast, plaque resident cells like endothelial cells (ECs) or vascular smooth muscle cells (VSMCs) that initiate and propagate local inflammatory processes are so far rather studied in experimental models. EC, for instance, which represent the major barrier between tissues and the blood stream, were successfully targeted experimentally 2 but the therapeutic potential of such approaches may be limited due to offsite effects that can be expected in other, non-diseased organs. These limitations can be overcome if we understand how local cells change their phenotype under disease conditions. In MATRICARD, a project funded by the European Research Council under the European Union's Horizon 2020 research and innovation programme within the Starting Grant scheme, we will focus on the role of the extracellular matrix (ECM) as a mediator of communication between different cell types in the vascular wall and the myocardium under inflammatory conditions ( Figure 1 ).

cardiac & cardiovascular systems